StonvexLoading…
StonvexStonvexStonvexCore line items from TGEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.34M | $27.07M | $21.76M | $14.57M |
Operating Income | $-2.14M | $-8.24M | $-4.11M | $-2.01M |
Net Income | $-2.12M | $-8.25M | $-4.25M | $-2.12M |
EPS (Diluted) | $-0.07 | $-0.30 | $-0.16 | $-0.08 |
Total Assets | $34.46M | $36.99M | $41.46M | $28.35M |
Total Liabilities | $14.92M | $15.52M | $16.15M | $19.41M |
Cash & Equivalents | $9.33M | $12.43M | $15.25M | $1.64M |
Free Cash Flow OCF − CapEx | $-3.15M | $-10.31M | $-7.69M | $-4.05M |
Shares Outstanding | 29.91M | 29.85M | 29.82M | 25.57M |